Isoptin Rr (Verapamil Hydrochloride)

Verapamil hydrochloride blocks L‑type calcium channels in cardiac and vascular smooth muscle. This inhibition reduces calcium entry into cells, leading to vasodilation, decreased myocardial contractility, and slowed atrioventricular nodal conduction, which together lower blood pressure and stabilize heart rhythm.

The specific dose of Isoptin Rr is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of verapamil during pregnancy or lactation has not been fully established. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing patients. Women should discuss their situation with a qualified medical professional.

To request Isoptin Rr, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isoptin Rr (verapamil) is a non‑dihydropyridine calcium channel blocker, primarily affecting cardiac conduction and contractility, whereas dihydropyridine agents such as amlodipine mainly cause peripheral vasodilation. Verapamil is often chosen for its anti‑arrhythmic properties, while other agents may be preferred for isolated hypertension.

Store Isoptin Rr at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Isoptin Rr is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include marked bradycardia, severe hypotension, and atrioventricular block, which can lead to fainting or cardiac arrest. Patients should be monitored for these events, especially when initiating therapy or adjusting doses.

Isoptin Rr is contraindicated in patients with known hypersensitivity to verapamil, severe left ventricular dysfunction, advanced heart block without a pacemaker, and in those with uncontrolled heart failure. Clinicians must evaluate each patient’s medical history before prescribing.